India, June 3 -- The Government of India has issued a release:
Scientists from Pune have reported a gene-silencing strategy that can drive effective tumor inhibition in breast cancer, highlighting its potential as next-generation precision nanomedicine.
Advances in cancer nanomedicine are increasingly shifting toward precision strategies that directly silence disease-driving genes while minimizing systemic toxicity.
Scientists from from the Agharkar Research Institute (ARI), Pune, an autonomous institute under the Department of Science and Technology (DST), Government of India, have presemted an innovative biodegradable nanocarrier platform engineered for targeted gene therapy in breast cancer.
The research, recently published in Advan...